Your browser doesn't support javascript.
loading
Innovations in Therapy Development for Rare Diseases Through the Rare Disease Cures Accelerator-Data and Analytics Platform.
Larkindale, Jane; Betourne, Alexandre; Borens, Amanda; Boulanger, Vanessa; Theurer Crider, Vickie; Gavin, Pamela; Burton, Jackson; Liwski, Richard; Romero, Klaus; Walls, Ramona; Barrett, Jeffrey S.
Afiliación
  • Larkindale J; Rare Disease Cures Accelerator - Data Analysis Platform (RDCA-DAP), Tucson, USA.
  • Betourne A; Rare Disease Cures Accelerator - Data Analysis Platform (RDCA-DAP), Tucson, USA.
  • Borens A; Data Collaboration Center (DCC), Tucson, USA.
  • Boulanger V; National Organization for Rare Disorders (NORD), Danbury, CT, USA.
  • Theurer Crider V; Data Collaboration Center (DCC), Tucson, USA.
  • Gavin P; National Organization for Rare Disorders (NORD), Danbury, CT, USA.
  • Burton J; Quantitative Medicine (QM) Groups, Critical Path Institute, Tucson, AZ, USA.
  • Liwski R; Data Collaboration Center (DCC), Tucson, USA.
  • Romero K; Quantitative Medicine (QM) Groups, Critical Path Institute, Tucson, AZ, USA.
  • Walls R; Data Collaboration Center (DCC), Tucson, USA.
  • Barrett JS; Rare Disease Cures Accelerator - Data Analysis Platform (RDCA-DAP), Tucson, USA. jbarrett@c-path.org.
Ther Innov Regul Sci ; 56(5): 768-776, 2022 09.
Article en En | MEDLINE | ID: mdl-35668316

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Raras / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ther Innov Regul Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Raras / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ther Innov Regul Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos